Jooeun Bae

1.3k total citations
37 papers, 1.1k citations indexed

About

Jooeun Bae is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Jooeun Bae has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 20 papers in Hematology and 18 papers in Molecular Biology. Recurrent topics in Jooeun Bae's work include Immunotherapy and Immune Responses (21 papers), Multiple Myeloma Research and Treatments (19 papers) and Immune Cell Function and Interaction (9 papers). Jooeun Bae is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), Multiple Myeloma Research and Treatments (19 papers) and Immune Cell Function and Interaction (9 papers). Jooeun Bae collaborates with scholars based in United States, Japan and South Korea. Jooeun Bae's co-authors include Kenneth C. Anderson, Nikhil C. Munshi, Yu‐Tzu Tai, Paul G. Richardson, Teru Hideshima, John Daley, Dharminder Chauhan, Rao Prabhala, Hans Klingemann and Noopur Raje and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Jooeun Bae

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jooeun Bae United States 17 578 513 472 453 68 37 1.1k
Helga Schmetzer Germany 22 886 1.5× 330 0.6× 533 1.1× 472 1.0× 32 0.5× 93 1.4k
Nahoko Suzuki Japan 8 505 0.9× 382 0.7× 422 0.9× 393 0.9× 15 0.2× 11 1.1k
Mehmet H. Kocoglu United States 15 243 0.4× 392 0.8× 455 1.0× 605 1.3× 64 0.9× 60 996
E. van de Wiel-van Kemenade Netherlands 16 651 1.1× 335 0.7× 373 0.8× 249 0.5× 185 2.7× 21 1.1k
Kelly M. Ramsbottom Australia 16 654 1.1× 414 0.8× 146 0.3× 462 1.0× 20 0.3× 22 1.0k
Herschel Wallen United States 7 715 1.2× 580 1.1× 107 0.2× 713 1.6× 31 0.5× 7 1.4k
Bart Nijmeijer Netherlands 16 134 0.2× 318 0.6× 249 0.5× 287 0.6× 84 1.2× 36 757
Daniel B. Rubinstein United States 13 296 0.5× 350 0.7× 191 0.4× 159 0.4× 142 2.1× 20 753
Yu Kyeong Hwang South Korea 17 486 0.8× 292 0.6× 95 0.2× 427 0.9× 34 0.5× 31 850
Udo F. Hartwig Germany 18 596 1.0× 273 0.5× 302 0.6× 370 0.8× 14 0.2× 38 1.1k

Countries citing papers authored by Jooeun Bae

Since Specialization
Citations

This map shows the geographic impact of Jooeun Bae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jooeun Bae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jooeun Bae more than expected).

Fields of papers citing papers by Jooeun Bae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jooeun Bae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jooeun Bae. The network helps show where Jooeun Bae may publish in the future.

Co-authorship network of co-authors of Jooeun Bae

This figure shows the co-authorship network connecting the top 25 collaborators of Jooeun Bae. A scholar is included among the top collaborators of Jooeun Bae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jooeun Bae. Jooeun Bae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bae, Jooeun, Fabrizio Accardi, Teru Hideshima, et al.. (2021). Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma. Leukemia. 36(1). 138–154. 51 indexed citations
3.
Hideshima, Teru, Jiye Liu, Takeshi Harada, et al.. (2020). Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways. Leukemia. 35(1). 177–188. 46 indexed citations
4.
Bae, Jooeun, Mehmet Samur, Paul G. Richardson, Nikhil C. Munshi, & Kenneth C. Anderson. (2019). Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy. Leukemia. 33(9). 2208–2226. 22 indexed citations
5.
6.
Bae, Jooeun, Teru Hideshima, Yu‐Tzu Tai, Nikhil C. Munshi, & Kenneth C. Anderson. (2019). Abstract B100: Development of fargeted multiple myeloma cancer vaccine and antigen-specific T-cell immunotherapy using novel Immunogenic-engineered heteroclitic BCMA peptides. Cancer Immunology Research. 7(2_Supplement). B100–B100. 1 indexed citations
7.
Gull, Nicole, Austin Yeon, Eunho Cho, et al.. (2018). Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1A. Scientific Reports. 8(1). 4505–4505. 11 indexed citations
8.
9.
Bae, Jooeun, Derin B. Keskin, Yu‐Tzu Tai, et al.. (2017). Pembrolizumab (anti-PD-1) Treatment Increases Anti-Tumor Activities of XBP1/CD138/CS1-Specific Cytotoxic T Lymphocytes Against Multiple Myeloma. Blood. 130. 1867–1867. 1 indexed citations
10.
11.
12.
Bae, Jooeun, Nikhil C. Munshi, & Kenneth C. Anderson. (2014). Immunotherapy Strategies in Multiple Myeloma. Hematology/Oncology Clinics of North America. 28(5). 927–943. 11 indexed citations
13.
Bae, Jooeun, Yu‐Tzu Tai, Kenneth C. Anderson, & Nikhil C. Munshi. (2011). Novel epitope evoking CD138 antigen‐specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders. British Journal of Haematology. 155(3). 349–361. 27 indexed citations
14.
Tai, Yu‐Tzu, Xianfeng Li, Laurence Catley, et al.. (2005). Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) Augments Anti-CD40 SGN-40–Induced Cytotoxicity in Human Multiple Myeloma: Clinical Implications. Cancer Research. 65(24). 11712–11720. 132 indexed citations
15.
Tai, Yu‐Tzu, Laurence Catley, Xianfeng Li, et al.. (2005). Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) Augments Anti-CD40 SGN-40-Induced Cytotoxicity in Human Multiple Myeloma: Clinical Implications.. Blood. 106(11). 5150–5150. 5 indexed citations
16.
Bae, Jooeun, Jeffrey Martinson, & Hans Klingemann. (2005). Identification of CD19 and CD20 Peptides for Induction of Antigen-Specific CTLs against B-Cell Malignancies. Clinical Cancer Research. 11(4). 1629–1638. 19 indexed citations
17.
Bae, Jooeun, Jeffrey Martinson, & Hans Klingemann. (2004). Identification of novel CD33 antigen-specific peptides for the generation of cytotoxic T lymphocytes against acute myeloid leukemia. Cellular Immunology. 227(1). 38–50. 10 indexed citations
18.
Prabhala, Rao, Paola Neri, Pierfrancesco Tassone, et al.. (2004). Dysregulated CD4+CD25+ T- Regulatory Cells and TLRs in Myeloma.. Blood. 104(11). 2466–2466. 3 indexed citations
19.
Bae, Jooeun, Gerhardt G. Schurig, & T. E. Toth. (2002). Mice immune responses to Brucella abortus heat shock proteins. Veterinary Microbiology. 88(2). 189–202. 19 indexed citations
20.
Bae, Jooeun & Thomas E. Toth. (2000). Cloning and kinetics of expression of Brucella abortus heat shock proteins by baculovirus recombinants. Veterinary Microbiology. 75(2). 199–204. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helga Schmetzer Breakdown of academic impact, for papers by Nahoko Suzuki Breakdown of academic impact, for papers by Mehmet H. Kocoglu Breakdown of academic impact, for papers by E. van de Wiel-van Kemenade Breakdown of academic impact, for papers by Kelly M. Ramsbottom Breakdown of academic impact, for papers by Herschel Wallen Breakdown of academic impact, for papers by Bart Nijmeijer Breakdown of academic impact, for papers by Daniel B. Rubinstein Breakdown of academic impact, for papers by Yu Kyeong Hwang Breakdown of academic impact, for papers by Udo F. Hartwig
Rankless by CCL
2026